FDA Inspection
Shandong Ruiying Pioneer Pharmaceutical Co., LtdShandong Ruiying Pioneer Pharmaceutical Co., Ltd – FDA Inspection, Mar 7, 2025
Record Details
This FDA Inspection record concerns Shandong Ruiying Pioneer Pharmaceutical Co., Ltd, with an inspection on March 7, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- March 7, 2025
- Product Type
- Human Drugs
View Company Profile
ID · 1cac6f1a-546d-4bc3-85ba-71da7351dbb6
Inspection Facts
- Inspection number
- 1264014
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
- FDA Inspection 1086433 - 2019-03-22
- FDA Inspection 920919 - 2015-03-27
- FDA Inspection 707439 - 2010-09-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.